Ambu Stock
Ambu Stock price
Key metrics
Is Ambu a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.
Ambu Stock Analysis
Analyst Opinions
14 Analysts have issued a Ambu forecast:
Analyst Opinions
14 Analysts have issued a Ambu forecast:
Financial data from Ambu
| Mar '25 |
+/-
%
|
||
| Revenue | 5,834 5,834 |
15%
15%
|
|
| Gross Profit | 3,516 3,516 |
20%
20%
|
|
| EBITDA | 1,003 1,003 |
40%
40%
|
EBIT (Operating Income) EBIT | 792 792 |
56%
56%
|
| Net Profit | 370 370 |
1%
1%
|
|
In millions DKK.
Don't miss a Thing! We will send you all news about Ambu directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
| Head office | Denmark |
| CEO | Britt Jensen |
| Employees | 5,000 |
| Founded | 1937 |
| Website | www.ambu.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
